Tenebroso, Maria Merlie Jane D.

HRN: 23-88-81  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/12/2023
AZITHROMYCIN 500MG TABLET (TAB)
10/12/2023
10/16/2023
PO
500mg
OD
CAP-MR; PTB Presumptive
Waiting Final Action 
10/12/2023
CEFTAZIDIME 1GM (VIAL)
10/12/2023
10/19/2023
IV
1g
Q8
CAP-MR; PTB Presumptive
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: